These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21663427)

  • 21. Effects of methylphenidate on working memory functioning in children with attention deficit/hyperactivity disorder.
    Kobel M; Bechtel N; Weber P; Specht K; Klarhöfer M; Scheffler K; Opwis K; Penner IK
    Eur J Paediatr Neurol; 2009 Nov; 13(6):516-23. PubMed ID: 19056305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits.
    Leitner Y; Doniger GM; Barak R; Simon ES; Hausdorff JM
    J Child Neurol; 2007 Mar; 22(3):264-76. PubMed ID: 17621495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of methylphenidate on cognitive function in children with attention-deficit/hyperactivity disorder.
    Kubas HA; Backenson EM; Wilcox G; Piercy JC; Hale JB
    Postgrad Med; 2012 Sep; 124(5):33-48. PubMed ID: 23095424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder.
    Kim BN; Kim JW; Cummins TD; Bellgrove MA; Hawi Z; Hong SB; Yang YH; Kim HJ; Shin MS; Cho SC; Kim JH; Son JW; Shin YM; Chung US; Han DH
    J Clin Psychopharmacol; 2013 Jun; 33(3):356-62. PubMed ID: 23609393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylphenidate-induced improvements of various measures of attention in adults with attention deficit hyperactivity disorder.
    Tucha O; Mecklinger L; Laufkötter R; Klein HE; Walitza S; Lange KW
    J Neural Transm (Vienna); 2006 Oct; 113(10):1575-92. PubMed ID: 16897610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender Differences in the Behavioral Symptoms and Neuropsychological Performance of Patients with Attention-Deficit/Hyperactivity Disorder Treated with Methylphenidate: A Two-Year Follow-up Study.
    Wang LJ; Chen CK; Huang YS
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):501-8. PubMed ID: 26262904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
    Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH
    Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder.
    Coghill DR; Rhodes SM; Matthews K
    Biol Psychiatry; 2007 Nov; 62(9):954-62. PubMed ID: 17543895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD.
    Hammerness P; Fried R; Petty C; Meller B; Biederman J
    Child Neuropsychol; 2014; 20(3):319-27. PubMed ID: 23639146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylphenidate improves Stroop naming speed, but not response interference, in children with attention deficit hyperactivity disorder.
    Bedard AC; Ickowicz A; Tannock R
    J Child Adolesc Psychopharmacol; 2002; 12(4):301-9. PubMed ID: 12625990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of osmotic-release methylphenidate in attention-deficit/hyperactivity disorder as measured by event-related potentials.
    Sawada M; Iida J; Ota T; Negoro H; Tanaka S; Sadamatsu M; Kishimoto T
    Psychiatry Clin Neurosci; 2010 Oct; 64(5):491-8. PubMed ID: 20923428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
    Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
    Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylphenidate improves reading performance in children with attention deficit hyperactivity disorder and comorbid dyslexia: an unblinded clinical trial.
    Keulers EH; Hendriksen JG; Feron FJ; Wassenberg R; Wuisman-Frerker MG; Jolles J; Vles JS
    Eur J Paediatr Neurol; 2007 Jan; 11(1):21-8. PubMed ID: 17169593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of methylphenidate on attentional functions in children with attention-deficit/hyperactivity disorder.
    Konrad K; Gunther T; Hanisch C; Herpertz-Dahlmann B
    J Am Acad Child Adolesc Psychiatry; 2004 Feb; 43(2):191-8. PubMed ID: 14726726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Executive impairment determines ADHD medication response: implications for academic achievement.
    Hale JB; Reddy LA; Semrud-Clikeman M; Hain LA; Whitaker J; Morley J; Lawrence K; Smith A; Jones N
    J Learn Disabil; 2011; 44(2):196-212. PubMed ID: 21383110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
    Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH
    Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of dual tasking and methylphenidate on gait in children with attention deficit hyperactivity disorder.
    Möhring W; Klupp S; Grob A
    Hum Mov Sci; 2018 Dec; 62():48-57. PubMed ID: 30243117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiological investigation of the effectiveness of methylphenidate in children with and without ADHD.
    Seifert J; Scheuerpflug P; Zillessen KE; Fallgatter A; Warnke A
    J Neural Transm (Vienna); 2003 Jul; 110(7):821-9. PubMed ID: 12811642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attention-deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood?
    Golubchik P; Kodesh A; Weizman A
    Clin Neuropharmacol; 2013; 36(5):141-5. PubMed ID: 24045603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.